HNN3.0

Project cooperationUpdated on 15 December 2025

GeneCore: Advanced Transcriptomics (Single-cell/Spatial) & High-Throughput Screening Partner

Head of Core Facility at Institute of Biotechnology of the Czech Academy of Sciences

Vestec, Czech Republic

About

GeneCore Facility (Institute of Biotechnology of the Czech Academy of Sciences) is an academic core facility offering over 18 years of expertise in advanced transcriptomics technologies. We provide holistic, scalable solutions for bulk, single-cell, and spatial transcriptomics, ideal for exploring disease mechanisms (DISEASE-11) and integrating New Approach Methodologies (TOOL-03). Our capabilities include:

  • Bulk RNA-seq: Analysis of mRNA and small RNA (biomarkers) in standard and challenging samples (low input, FFPE).

  • High-Throughput NAMs: Scalable in-vitro screening solutions without RNA isolation, enabling cost-effective high-throughput drug/toxicity testing.

  • Single-Cell Experts: We cover the full spectrum from highly sensitive targeted plate-based approaches (SmartSeq3xpress) and industry-standard 10x Genomics, to high-throughput complementary techniques (Parse Bioscience, Scale Biosciences).

  • Spatial & Sequencing: Sequencing-based spatial transcriptomics and access to the latest instruments (Illumina, Element Biosciences).

We offer a complete service package including experimental design, hands-on protocols, established QC workflows, and interactive data visualization. We are looking to join a consortium as a partner to provide exploratory or explanatory in-depth transcriptomic analysis at any scale.

Topic

  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

Type

  • Partner seeks Consortium/Coordinator

Attached files

Organisation

Similar opportunities